Related Experiment Video
Updated: Feb 28, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Sedation Management in Children Supported on Extracorporeal Membrane Oxygenation for Acute Respiratory Failure
James B Schneider1, Todd Sweberg, Lisa A Asaro
11Division of Pediatric Critical Care Medicine, Department of Pediatrics, Cohen Children's Medical Center, Hofstra-Northwell School of Medicine, New York, NY. 2Department of Cardiology, Boston Children's Hospital, Boston, MA. 3Division of Pediatric Critical Care Medicine, Oregon Health & Science University School of Medicine, Portland, OR. 4Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA. 5Department of Pediatrics, Harvard Medical School, Boston, MA. 6Department of Family and Community Health, School of Nursing, University of Pennsylvania, Philadelphia, PA. 7Division of Anesthesia and Critical Care Medicine at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. 8Critical Care and Cardiovascular Program, Boston Children's Hospital, Boston, MA.
Insights
Extracorporeal membrane oxygenation (ECMO) in children with respiratory failure requires deep sedation and leads to increased sedative exposure and withdrawal. A standardized sedation protocol may reduce these adverse effects.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacology and Therapeutics
- Respiratory Physiology
Background:
- Sedation management in children requiring extracorporeal membrane oxygenation (ECMO) for acute respiratory failure is complex.
- Understanding sedative exposure and its consequences is crucial for optimizing patient care.
Purpose of the Study:
- To describe sedation management strategies in pediatric patients supported by ECMO.
- To evaluate the impact of a standardized sedation protocol (Randomized Evaluation of Sedation Titration for Respiratory Failure - RESTORE) on sedative exposure and outcomes.
Main Methods:
- Secondary analysis of prospectively collected data from a multicenter randomized trial involving 1255 children with moderate/severe pediatric acute respiratory distress syndrome.
- Comparison of sedation management between usual care and the RESTORE protocol in 61 ECMO patients.
Main Results:
- ECMO patients received deep sedation, neuromuscular blockade, and substantial opioid/benzodiazepine doses, which increased significantly by day 3.
- ECMO patients experienced more iatrogenic withdrawal syndrome compared to non-ECMO patients.
- Patients managed with the RESTORE protocol received fewer opioids and had shorter exposure days than those receiving usual care.
Conclusions:
- ECMO initiation in children is linked to deep sedation, high sedative exposure, and increased iatrogenic withdrawal.
- A standardized, goal-directed, nurse-driven sedation protocol, like RESTORE, may mitigate these adverse effects in ECMO patients.
Objectives:
To describe sedation management in children supported on extracorporeal membrane oxygenation for acute respiratory failure.
Design:
Secondary analysis of prospectively collected data from a multicenter randomized trial of sedation (Randomized Evaluation of Sedation Titration for Respiratory Failure).
Setting:
Twenty-one U.S. PICUs.
Patients:
One thousand two hundred fifty-five children, 2 weeks to 17 years old, with moderate/severe pediatric acute respiratory distress syndrome.
Interventions:
Sedation managed per usual care or Randomized Evaluation of Sedation Titration for Respiratory Failure protocol.
Measurements And Main Results:
Sixty-one Randomized Evaluation of Sedation Titration for Respiratory Failure patients (5%) with moderate/severe pediatric acute respiratory distress syndrome were supported on extracorporeal membrane oxygenation, including 29 managed per Randomized Evaluation of Sedation Titration for Respiratory Failure protocol. Most extracorporeal membrane oxygenation patients received neuromuscular blockade (46%) or were heavily sedated with State Behavioral Scale scores -3/-2 (34%) by extracorporeal membrane oxygenation day 3. Median opioid and benzodiazepine doses on the day of cannulation, 0.15 mg/kg/hr (3.7 mg/kg/d) and 0.11 mg/kg/hr (2.8 mg/kg/d), increased by 36% and 58%, respectively, by extracorporeal membrane oxygenation day 3. In the 41 patients successfully decannulated prior to study discharge, patients were receiving 0.40 mg/kg/hr opioids (9.7 mg/kg/d) and 0.39 mg/kg/hr benzodiazepines (9.4 mg/kg/d) at decannulation, an increase from cannulation of 108% and 192%, respectively (both p < 0.001). Extracorporeal membrane oxygenation patients experienced more clinically significant iatrogenic withdrawal than moderate/severe pediatric acute respiratory distress syndrome patients managed without extracorporeal membrane oxygenation support (p < 0.001). Compared to extracorporeal membrane oxygenation patients managed per Randomized Evaluation of Sedation Titration for Respiratory Failure protocol, usual care extracorporeal membrane oxygenation patients received more opioids during the study period (mean cumulative dose of 183.0 vs 89.8 mg/kg; p = 0.02), over 6.5 greater exposure days (p = 0.002) with no differences in wakefulness or agitation.
Conclusions:
In children, the initiation of extracorporeal membrane oxygenation support is associated with deep sedation, substantial sedative exposure, and increased frequency of iatrogenic withdrawal syndrome. A standardized, goal-directed, nurse-driven sedation protocol may help mitigate these effects.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
Endotracheal Tube Extubation
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....
Cardiopulmonary Resuscitation II: ACLS Airway Management
Parenteral Anesthetics: Overview
Acute Respiratory Failure-IV

